Public
Inquiries
English (888) 246-2675
Español (888) 246-2857
TTY (866) 874-2646
Mon-Fri 8am-11pm EST
Sat-Sun 10am-8pm EST
Centers for Disease Control and Prevention
1600 Clifton Rd.
Atlanta, GA 30333
USA
(404) 639-3311 |
|
 |
Chemical
Agents > Soman > |
 |
Emergency
Response Card: Information for First Responders - Nerve Agent: Soman |
NERVE
AGENT
CAS
# 96-64-0; 50642-24-5
RTECS #
Counter Terrorism Card 0004 |
SOMAN
GD
thickened GD (TGB)
methylphosphonofluoridic acid
1,2,2-trimethylpropyl ester
Phosphonofluoridic acid, methyl-,1,2,2-trimethylpropyl
ester
Pinacolyl methyl phosphonofluoridate
O-Pinalcolyl methylphosphonofluoridate
Chemical Formula C7H16FO2P
Molecular mass: 182.19 |
|
TYPES OF
HAZARD/
EXPOSURE |
ACUTE HAZARDS/
SYMPTOMS |
PREVENTION |
FIRST AID/
FIRE FIGHTING |
FIRE |
React
with steam or water to produce toxic and corrosive vapors.
|
Contain
to prevent contamination to uncontrolled areas. |
Water
mist, fog, and foam, CO2. Avoid using extinguishing
methods that will cause splashing or spreading. |
EXPLOSION |
Hydrogen
may be produced by the corrosive vapors reacting with
metals, concrete, etc. |
|
|
EXPOSURE |
· Liquid or vapors can be fatal. |
Do
not breathe fumes.
Skin contact must be avoided at all times. |
Seek
medical attention Immediately. |
|
Symptoms
may occur within minutes or hours, depending upon dose.
Same
sequence of symptoms despite the route of exposure:
MILD
· runny nose
· tightness of the chest and
breathing difficulty
· eye pain, dimness of vision
and pin pointing of pupils (miosis)
· difficulty in breathing and
cough
MODERATE
· increased eye symptoms with
blurred vision
· drooling and excessive sweating
· severe nasal congestion
· increased tightness of the
chest and breathing difficulty
· nausea, vomiting, diarrhea,
and cramps
· generalized weakness, twitching
of large muscle groups
· headache, confusion, and drowsiness
SEVERE
· involuntary defecation and
urination
· very copious secretions
· twitching, jerking, staggering
and convulsions
· cessation of breathing, loss
of consciousness, coma and death. |
Hold
breath until respiratory protective mask is donned.
Fire-fighting
personnel should wear full protective clothing and respiratory
protection during fire-fighting and rescue.
Positive
pressure, full face piece, NIOSH-approved self-contained
breathing apparatus (SCBA) will be worn. |
· If severe signs, immediately
administer, in rapid succession, all three Nerve Agent
Antidote Kit(s), Mark I injectors (or atropine if directed
by a physician).
· If signs and symptoms are
progressing, use injectors at 5 to 20 minute intervals.
(No more than 3 injections unless directed by medical
personnel.)
· Maintain record of all injections
given.
· Give artificial respiration
if breathing has stopped. Use mouth-to-mouth when mask-bag
or oxygen delivery systems not available. Do not use mouth-to-mouth
if face is contaminated.
· Administer oxygen if breathing
is difficult. |
|
See
Inhalation
Pupil
size may range from nomal to moderately reduced. |
Protective
Gloves: Butyl Rubber Glove M3 and M4 Norton, Chemical
Protective Glove Set |
The
primary mode for decontamination of chemical agents is soap and water.
A 0.5% hypochlorite solution can be used. There are differing
guidelines for decontamination and more research is needed
to identify the optimal decontamination method.
See "Personal Decontamination" and "Appendix
D" in
Treatment of Chemical Agent Casualties and Conventional
Military Chemical Injuries (from the U.S. Navy Counterproliferation
Office).
See also the Medical
Management of Chemical Casualties Handbook (from the
U.S. Army Medical Research Institute of Chemical Defense
[USAMRICD]) for a general review of the issues and more
on the military decontamination powder approach. |
|
See
Inhalation
Very
rapid onset of symptoms. |
Chemical
goggles and face shield. |
Immediately
flush eyes with water for 10-15 minutes, then don respiratory
protective mask.
Symptoms of only miosis does
not warrant antidote injection. |
|
See
Inhalation
Pupil
size may range from normal to moderately reduced. |
|
Do
not induce vomiting. First symptoms are likely to be gastrointestinal.
Immediately administer Nerve Agent Antidote Kit, Mark
I. |
DECONTAMINATION |
SPILLAGE
DISPOSAL |
PACKAGING
& LABELLING |
- solids, powders and solutions containing various
types of bleach (NaOCl or
Ca(OCl)2)
- DS2 (2% NaOH, 70%
diethylenetriamine, 28% ethylene glycol monomethyl ether)
- towelettes moistened with NaOH
dissolved in water, phenol, ethanol, and ammonia.
|
Cover
with vermiculite, diatomaceous earth, clay, fine sand,
sponges, and paper or cloth towels. Treat with large amounts
of aqueous sodium hydroxide solution (minimum 10 % by
weight). Scoop decontaminated material and place in approved
container. After sealing, decontaminate the exterior and
label. All leaking containers will be over packed with
sorbent (e.g. vermiculite) placed
between the interior and exterior containers. Label and
dispose according to regulations. Conduct general area
monitoring.
If aqueous sodium hydroxide is not available, use following
in the order of preference: Decontaminating Agent (DS2),
Sodium Carbonate, and Supertropical Bleach Slurry (STB). |
Proper
Shipping Name: Toxic liquids, organic, n.o.s.
DOT Hazard Class: 6.1, Packing Group I, Hazard Zone
B
DOT Label: Poison
DOT Marking: Toxic liquids, organic, n.o.s.
(Pinacolyl methyl phosphonofluoridate)
UN 2810, Inhalation Hazard
DOT Placard: |
NFPA
704 Signal:
- Health - 4
- Flammability - 1
- Reactivity - 1
- Special - 0
|
|
|
|
|
I
M
P
O
R
T
A
N
T
D
A
T
A
|
PHYSICAL STATE; APPEARANCE:
When pure, colorless
liquid with a fruity odor. With impurities, amber or dark
brown with camphor odor.
PHYSICAL DANGERS:
CHEMICAL DANGERS:
Stable in steel for 3 months at 65°C.
OCCUPATIONAL EXPOSURE LIMITS (OELs):
TLV : 0.00003 mg/m3 (military not ACGIH)
|
ROUTES OF EXPOSURE:
The substance
can be absorbed into the body by all routes.
INHALATION RISK:
Usually liquid in normal state, but will volatilize
if heated to form vapor or aerosol.
EFFECTS OF SHORT-TERM EXPOSURE:
Soman, an organophosphorus
compound, is a lethal cholinesterase inhibitor similar in
action to GA (Tabun), although about twice as toxic by inhalation.
EFFECTS OF LONG-TERM OR REPEATED EXPOSURE:
Limited data suggest delayed neuropathy (postural sway,
psychomotor performance). Miosis
has been noted up to 62 days. |
|
PHYSICAL
PROPERTIES |
melting
point: -80 to -42°C
boiling point: 190-198°C
vapor pressure (20°C): 0.92mm Hg
density (20°C): 1.01g /cm3
volatility: 3900 mg/m3 at 25°C
specific gravity: 1.0252 at 25°C |
aqueous
solubility (0°C): 34 g /L
Soluble in sulfur mustard, gasoline, alcohols, fats, and
oils.
estimated log Kow:
1.78
log Kbenzene-water:
1.61
flashpoint: 121 °C (Open Cup Method)
flammability: not available |
|
ENVIRONMENTAL
DATA |
Hydrolysis
by acidic, neutral, and basic mechanisms, giving
fluoride and pinacolyl methylphosphonate.
Rapidly hydrolyzed in basic solutions, e.g., Na2CO3,
NaOH, or KOH with a half-life of approximately 1 minute
at pH 11 at 25°C.
Soman and its hydrolysis products exhibit
no significant phototransformations
in sunlight.
Soman and its hydrolysis products are
thermally stable at temperatures less than 49°C. |
N O T E S |
|
ADDITIONAL INFORMATION |
Trade
Names and Other Synonyms:
- 3,3 dimethyl-n-but-2-yl methylphosphonofluridate
- 1,2,2-Trimethylpropyl methylphosphonofluoridate
- Methylpinacolyloxyfluorophosphine oxide
- Pinacolyloxymethylphosphonyl fluoride
- Pinacolyl methanefluorophosphonate
- Methylfluoropinacolylphosphonate
- Fluoromethylpinacolyloxyphosphine oxide
- Methylpinacolyloxyphosphonyl fluoride
- Pinacolyl methylfluorophosphonate
- 1,2,2-Trimethylpropoxyfluoromethylphosphine oxide
- EA 1210
- Zoman
- PFMP
|
Styrene-butyl
acrylate copolymer is used to thicken GD (TGD) and is not
known to be hazardous except in a finely-divided, powder form.
The same information above applies to the thickened form except
for spills, dissolve TGD in acetone before introducing any decontaminating
solution. For skin contact, in addition to donning a respiratory
protective mask and immediately removing contaminated clothing, scrape the TGD
from the skin surface, then wash with acetone. |
IMPORTANT NOTICE: |
SOMAN
(CTC: 0004) Neither the CDC or NIOSH nor any person acting on
behalf of the CDC or NIOSH is responsible for the use
which might be made of this information. This card contains
the collective views of these agencies and may not reflect
in all cases all the detailed requirements in response
to a terrorism event on the subject. The user should verify
compliance of the cards with the relevant STATE or TERRITORY
legislation before use. NIOSH, CDC 2000 |
|
|